Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;67(12):2482-2489.
doi: 10.1111/jgs.16212. Epub 2019 Oct 24.

Polypharmacy and Incident Frailty in a Longitudinal Community-Based Cohort Study

Shahar Shmuel  1 , Jennifer L Lund  1 , Carolina Alvarez  2 , Christine D Hsu  1 , Priya Palta  1 , Anna Kucharska-Newton  1   3 , Joanne M Jordan  1   2   4 , Amanda E Nelson  2   4 , Yvonne M Golightly  1   2   5   6
Affiliations

Polypharmacy and Incident Frailty in a Longitudinal Community-Based Cohort Study

Shahar Shmuel et al. J Am Geriatr Soc. 2019 Dec.

Abstract

Objectives: Polypharmacy may affect frailty, a common and costly condition among older adults. Frailty prevalence is elevated among racial/ethnic minorities and persons living in the US South, and research is needed to inform future pharmacologic interventions in these populations. Our aim was to quantify the prevalence of frailty and polypharmacy, and to estimate the association between polypharmacy and incident frailty.

Design: Prospective cohort study.

Setting: A community-based cohort study of adults residing in Johnston County, North Carolina.

Participants: White and African American adults aged 50 to 95 years (n=1697).

Measurements: At each study visit, all prescription and over-the-counter medications were recorded. We calculated annual polypharmacy (5-9 medications) and excessive polypharmacy (≥10 medications) prevalence at the 2006-2010 visit (n = 1697) and operationalized the Fried frailty phenotype to describe prevalent and incident frailty at two consecutive visits (2006-2010 and 2013-2015). We estimated risk ratios (RRs) and 95% confidence intervals (CIs) for the association between polypharmacy and incident frailty using weighted log-binomial regression to account for measured confounding and attrition using inverse probability of treatment and attrition weights, respectively.

Results: At the 2006-2010 visit, 678 (41%) and 260 (16%) participants were exposed to polypharmacy and excessive polypharmacy, respectively. Overall, 353 (21%) participants and 180 (21%) participants were frail at the 2006-2010 and 2013-2015 visits, respectively. Frailty was more common among participants identifying as white, women, and having less educational attainment relative to those without these characteristics. Incident frailty at the 2013-2015 visit was 15% (mean follow-up = 5.5 years). Our results suggest that polypharmacy is positively associated with incident frailty (weighted RR = 1.4; 95% CI = .9-2.0), yet estimates are imprecise and should be interpreted with caution.

Conclusion: Consistent with the current weight of evidence, our results suggest an association between polypharmacy and incident frailty. Prospective studies evaluating deprescribing interventions are needed to clarify whether reducing polypharmacy decreases frailty incidence. J Am Geriatr Soc 67:2482-2489, 2019.

Keywords: aging health; cohort study; epidemiology; frailty; polypharmacy.

PubMed Disclaimer

Comment in

  • Drug Therapy and Frailty: Chicken or the Egg?
    Rochon PA, Stall NM, Holmes HM. Rochon PA, et al. J Am Geriatr Soc. 2019 Dec;67(12):2441-2443. doi: 10.1111/jgs.16213. Epub 2019 Oct 24. J Am Geriatr Soc. 2019. PMID: 31648366 No abstract available.

References

REFERENCES

    1. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.
    1. Bandeen-Roche K, Xue Q-L, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61(3):262-266.
    1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752-762.
    1. Clegg A, Young J. The frailty syndrome. Clin Med. 2011;11(1):72-75.
    1. de Vries NM, Staal JB, van Ravensberg CD, Hobbelen JSM, Olde Rikkert MGM, Nijhuis-van der Sanden MWG. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev. 2011;10(1):104-114.

Publication types

LinkOut - more resources